SCHEMBL20174376

SCHEMBL20174376

c1ccc2c(c1)-c1ccccc1C21c2ccc(-c3nc(-c4ccncc4)nc(-c4ccncc4)n3)cc2-c2c1oc1ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.37
SMN1; SMN2 Q16637 6/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 4/20 0.35
MAPT P10636 4/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 3/20 0.35
LMNA P02545 3/20 0.35
MAPK1 P28482 1/20 0.35
PDK2 Q15119 1/20 0.34
HTT P42858 2/20 0.32
TSHR P16473 1/20 0.32
ACE2 Q9BYF1 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174400 0.87 S1PR1 (0.34) SMN1; SMN2ALDH1A1KDM4EMAPTNPC1
SCHEMBL20174399 0.86 KDM4E (0.38) MAPK14SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL20174412 0.85 SMN1; SMN2 (0.38) MAPK14SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL20174414 0.85 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1KDM4EMAPTNPC1
SCHEMBL20174413 0.84 ALK (0.35) MAPTLMNAHTTTSHRKMT2A
SCHEMBL20174419 0.83 PDK2 (0.46) MAPK14PDK2GSK3BALK
SCHEMBL20174385 0.82 KMT2A (0.34) SMN1; SMN2ALDH1A1KDM4EMAPTHSD17B10
SCHEMBL20174359 0.82 KMT2A (0.34) ALDH1A1KDM4EMAPTHPGDLMNA
SCHEMBL22930619 0.81 KDM4E (0.36) MAPK14SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL20174354 0.81 PDK2 (0.37) ALDH1A1MAPTHPGDLMNAPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPK14 3746/4885SMN1; SMN2 3407/4885ALDH1A1 33/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPK14 3746/4885SMN1; SMN2 3407/4885ALDH1A1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.